| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.7M | — | — |
| Cost of Revenue | $2.8M | — | — |
| Gross Profit | $914K | — | — |
| R&D Expense | $86K | +3892.3% | — |
| SG&A Expense | $19K | -78.2% | -76.8% |
| Operating Income | $467K | +624.5% | +671.8% |
| Income Tax | -$14K | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $394K | +5.5% | — |
| Accounts Receivable | $1.0M | +6.9% | — |
| Inventory | $1.5M | +19.9% | — |
| Current Assets | $5.5M | -2.3% | — |
| Total Assets | $16.9M | +18.4% | — |
| Current Liabilities | $4.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Investing Cash Flow | $153K | — | — |
| Financing Cash Flow | $455K | — | — |
| — |
| Net Income | $429K | +556.9% | +612.5% |
| EPS (Basic) | $0.01 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| +12.8% |
| +952.7% |
| Total Liabilities | $5.1M | +32.0% | +1131.7% |
| Stockholders' Equity | $11.1M | +6.3% | +2889.5% |